Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment

<p class="p p-first-last" id="__p2">After rifampin and levofloxacin treatment for a <em>Staphylococcus aureus</em> bone infection, a pyogenic granuloma due to a newly described <em>Cutibacterium</em> species,<em> C. namnetense</em> develo...

Full description

Bibliographic Details
Main Authors: S. Corvec, A. Guillouzouic, G. G. Aubin, S. Touchais, O. Grossi, F. Gouin, P. Bémer
Format: Article
Language:English
Published: Copernicus Publications 2018-11-01
Series:Journal of Bone and Joint Infection
Online Access:https://jbji.copernicus.org/articles/3/255/2018/jbji-3-255-2018.pdf
id doaj-81924222deb341618707c9ef35dfc760
record_format Article
spelling doaj-81924222deb341618707c9ef35dfc7602021-03-03T14:48:15ZengCopernicus PublicationsJournal of Bone and Joint Infection2206-35522018-11-01325525710.7150/jbji.30029Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection TreatmentS. Corvec0S. Corvec1S. Corvec2A. Guillouzouic3G. G. Aubin4S. Touchais5S. Touchais6O. Grossi7O. Grossi8F. Gouin9F. Gouin10P. Bémer11P. Bémer12Service de Bactériologie-Hygiène hospitalière, CHU de Nantes, Nantes, FranceCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, FranceNantes study group member of CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest), Nantes, FranceService de Bactériologie-Hygiène hospitalière, CHU de Nantes, Nantes, FranceService de Bactériologie-Hygiène hospitalière, CHU de Nantes, Nantes, FranceNantes study group member of CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest), Nantes, FranceClinique chirurgicale orthopédique et traumatique, CHU de Nantes, Nantes, France.Nantes study group member of CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest), Nantes, FranceService de Maladies infectieuses, CHU de Nantes, Nantes, France - Département de Médecine Interne -Infectiologie, Nouvelles Cliniques Nantaises, Nantes, FranceNantes study group member of CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest), Nantes, FranceClinique chirurgicale orthopédique et traumatique, CHU de Nantes, Nantes, France.Service de Bactériologie-Hygiène hospitalière, CHU de Nantes, Nantes, FranceNantes study group member of CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest), Nantes, France<p class="p p-first-last" id="__p2">After rifampin and levofloxacin treatment for a <em>Staphylococcus aureus</em> bone infection, a pyogenic granuloma due to a newly described <em>Cutibacterium</em> species,<em> C. namnetense</em> developed on the tibia former external fixator. This rifampin resistant bacterium, selected during treatment, harbored a mutation in the <em>rpoB</em> gene. This case illustrates the possible <em>in vivo</em> selection of resistant mutant most likely due to the bacterial burden and therefore the importance of adequate bone infection treatment.</p>https://jbji.copernicus.org/articles/3/255/2018/jbji-3-255-2018.pdf
collection DOAJ
language English
format Article
sources DOAJ
author S. Corvec
S. Corvec
S. Corvec
A. Guillouzouic
G. G. Aubin
S. Touchais
S. Touchais
O. Grossi
O. Grossi
F. Gouin
F. Gouin
P. Bémer
P. Bémer
spellingShingle S. Corvec
S. Corvec
S. Corvec
A. Guillouzouic
G. G. Aubin
S. Touchais
S. Touchais
O. Grossi
O. Grossi
F. Gouin
F. Gouin
P. Bémer
P. Bémer
Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment
Journal of Bone and Joint Infection
author_facet S. Corvec
S. Corvec
S. Corvec
A. Guillouzouic
G. G. Aubin
S. Touchais
S. Touchais
O. Grossi
O. Grossi
F. Gouin
F. Gouin
P. Bémer
P. Bémer
author_sort S. Corvec
title Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment
title_short Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment
title_full Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment
title_fullStr Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment
title_full_unstemmed Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment
title_sort rifampin-resistant <em>cutibacterium</em> (formerly <em>propionibacterium</em>) <em>namnetense</em> superinfection after <em>staphylococcus aureus</em> bone infection treatment
publisher Copernicus Publications
series Journal of Bone and Joint Infection
issn 2206-3552
publishDate 2018-11-01
description <p class="p p-first-last" id="__p2">After rifampin and levofloxacin treatment for a <em>Staphylococcus aureus</em> bone infection, a pyogenic granuloma due to a newly described <em>Cutibacterium</em> species,<em> C. namnetense</em> developed on the tibia former external fixator. This rifampin resistant bacterium, selected during treatment, harbored a mutation in the <em>rpoB</em> gene. This case illustrates the possible <em>in vivo</em> selection of resistant mutant most likely due to the bacterial burden and therefore the importance of adequate bone infection treatment.</p>
url https://jbji.copernicus.org/articles/3/255/2018/jbji-3-255-2018.pdf
work_keys_str_mv AT scorvec rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT scorvec rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT scorvec rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT aguillouzouic rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT ggaubin rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT stouchais rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT stouchais rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT ogrossi rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT ogrossi rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT fgouin rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT fgouin rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT pbemer rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
AT pbemer rifampinresistantemcutibacteriumemformerlyempropionibacteriumememnamnetenseemsuperinfectionafteremstaphylococcusaureusemboneinfectiontreatment
_version_ 1724232801121730560